Lite Strategy Stock (NASDAQ:LITS)
Previous Close
$1.38
52W Range
$0.69 - $2.97
50D Avg
$1.06
200D Avg
$1.11
Market Cap
$46.95M
Avg Vol (3M)
$429.85K
Beta
0.04
Div Yield
-
LITS Company Profile
Lite Strategy, Inc. functions as a clinical-stage pharmaceutical firm, concentrating its efforts on creating innovative and distinct therapeutic solutions for cancer patients. This entity, which was previously known as MEI Pharma, Inc., officially changed its designation to Lite Strategy, Inc. in September 2025. The company was established in 2000 and has its principal operations located in San Diego, California.